PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 219 results · Off-label Promotion  · Clear
🔒 Subscribers only
AUTH/3646/5/22
Off-label Promotion Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
An anonymous health professional complained about Roche’s HCP-gated Roche Resources promotional webpage for Rozlytrek (entrectinib) focused on dosing considerations (material code M-GB-00004833; …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3706/11/22
Off-label Promotion Not Upheld 🏥 Other ▶ Video 🎙 Podcast
CSL Vifor
An ex-employee complained about CSL Vifor’s non-promotional service/tools offered to NHS Trusts to support pre-operative anaemia screening and treatment service development.The complainant allege…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3650/5/22
Off-label Promotion Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Eli Lilly v UCB
Eli Lilly complained about three claims in a UCB promotional leavepiece for Bimzelx (bimekizumab) aimed at dermatology health professionals (Sept 2021 leavepiece ref IL-P-BK-PSD-2100004; updated No…
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3673/7/22
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo press release on Nilemdo/Nustendi
An anonymous, contactable complainant challenged a Daiichi Sankyo UK press release about Nilemdo (bempedoic acid) and Nustendi (bempedoic acid/ezetimibe). The press release (issued to UK journalist…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3467/2/21
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Anonymous GP v Pfizer
An anonymous, non-contactable complainant describing themself as a GP complained about a named Pfizer representative’s promotion of Eliquis (apixaban), an anticoagulant.The GP alleged the represe…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3481/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (described as a Sanofi employee) raised concerns about internal communications relating to Suliqua (insulin glargine with lixisenatide).An internal email c…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3486/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (self-described health professional) complained about alleged off-licence promotion of Suliqua (insulin glargine + lixisenatide) by Sanofi.The complainant …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3491/3/21
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
Sanofi
An anonymous, non-contactable complainant (self-described health professional) alleged off-licence promotion of Suliqua (insulin glargine/lixisenatide) by Sanofi.The complainant said a diabetes nur…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3449/1/21
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Small Pharma
An anonymous, contactable complainant challenged statements in a December 2020 Guardian article about DMT being trialled in the UK to treat depression.The article included a quotation attributed to…
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3501/4/21
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
LEO Pharma
An anonymous complainant challenged multiple claims and visuals on the ‘At a glance’ section (ref MAT-21383) of uk.dermaworld.eu (intended for UK/Ireland health professionals) promoting Protopi…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3592/12/21
Off-label Promotion Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
Inter-company complaint by Bayer plc about a Janssen promotional on-demand video for Erleada (apalutamide) tablets: “Castration-resistant prostate cancer: The evidence supporting the benefits of …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3445/12/20
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk Ozempic email alleged off-label promotion to under-18s (No breach)
A health professional complained about a Novo Nordisk promotional email for Ozempic (semaglutide) (ref UK20OZM00311) sent via Pulse.The email referenced SUSTAIN 7 data and included claims such as �…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3425/11/20
Off-label Promotion Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AUTH/3425/11/20 & AUTH/3426/11/20
The Royal College of General Practitioners (RCGP) Overdiagnosis Group complained about a promotional email for Eliquis (apixaban) (ref PP-ELI-GBR-6974) sent jointly by Pfizer Limited and Bristol-My…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3427/11/20
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Eli Lilly complained about two Novo Nordisk slide decks on cardiovascular outcome trials (CVOTs) in type 2 diabetes (refs UK19OZM00368 Nov 2019 and UK20DI00110 April 2020). The complaint focused on…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3312/2/20
Off-label Promotion Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Johnson & Johnson
An anonymous UK health professional complained about a journal advertisement for Nicorette (nicotine) (ref UK/NI/19-14927a) placed in Guidelines in Practice (January 2020 edition).The ad’s prescr…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3313/2/20
Off-label Promotion Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Tillotts
A UK health professional complained about a journal advertisement for Octasa 1600mg (modified release mesalazine) placed by Tillotts Pharma UK Limited (ref PU-00264) in the January 2020 edition of …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3344/5/20
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Britannia Pharmaceuticals
A health professional said they had emailed Britannia Pharmaceuticals Ltd three times over 12 months asking to be removed from all mailing lists, but still received an emailed copy of Kinetic from …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3360/6/20
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Glenmark and iQ Pharma
An anonymous, non-contactable NHS employee complained about promotional material for Renocontin (prolonged release oxycodone hydrochloride) (ref PP-UK-REN-0002).The material was issued by CactusRx …
Clauses: 9.1,9.2,9.3
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3326/3/20
Off-label Promotion Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Norgine
Norgine made claims for Feraccru (oral ferric maltol) including: “In the new head-to-head trial, Feraccru was found to be non-inferior to IV ferric carboxymaltose” and “Feraccru may be an app…
Clauses: 9.1,9.2
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3240/8/19
Off-label Promotion Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Colonis
Colonis Pharma Limited made a voluntary admission that a promotional letter (ref UK-CPL-121-008) about Melatonin 1mg/ml Oral Solution (indicated for short-term treatment of jet-lag in adults) inclu…
Clauses: 4.1,4.3
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3215/6/19
Off-label Promotion Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
GP v Pfizer and Bristol-Myers Squibb
A general practitioner complained about a page from a six-page, landscape, gatefold leavepiece promoting Eliquis (apixaban) (ref PP-ELI-GBR-4453) issued by Pfizer Limited and Bristol-Myers Squibb P…
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3221/6/19
Off-label Promotion Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Colonis Pharma Limited — Melatonin 1mg/ml Oral Solution
An NHS trust medicines information pharmacist complained about a promotional letter (ref UK-CPL-121-008) sent by Colonis Pharma Limited promoting Melatonin 1mg/ml Oral Solution.The product was indi…
Clauses: 7.2,7.4,9.1
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3245/9/19
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous, contactable individual describing themself as a GP (later noted to be assisted by an ex-employee during the appeal) complained about Novo Nordisk representatives’ promotion of Ozemp…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3264/10/19
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Merz
An anonymous complainant alleged unethical cross-border activity involving Bocouture (botulinum toxin type A) between Northern Ireland (licensed) and the Republic of Ireland (not licensed).A UK-reg…
Clauses: NONE
2019 🔒 Subscribe
← Prev 1 2 3 4 5 Next → Page 2 of 10 — 219 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews